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Abstract
The coronary artery calcification score and pericardial fat volume have recently been reported to be strongly associated with the severity
and presence of coronary atherosclerosis. However, no studies have explored the outcome of phased progression of atherosclerosis by
non-contrast computed tomography in asymptomatic people in China. The population-based cohort study in outcome of phased progression
of atherosclerosis in China (PERSUADE), an observational, longitudinal and prospective cohort study in a target population of healthy subjects based in Jidong Oilfield (China), prospectively analyzes the outcome of phased progression of atherosclerosis by non-contrast computed
tomography in healthy population. The results of this study are expected to be of value for utilizing noninvasive imaging combine with traditional cardiovascular risk factors to create a risk stratification and find pertinent biomarkers associated with the outcome of phased progression of atherosclerosis in healthy people, thereby could help to establish a more personalized treatment of clinical practice.
J Geriatr Cardiol 2017; 14: 491495. doi:10.11909/j.issn.1671-5411.2017.08.001
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1 Background 
Atherosclerosis is the underlying cause of most cardiovascular diseases and the leading cause of death and disability world wide. Currently, it has been illustrated that atherosclerosis starts with fatty streaks formation and progresses
with atherosclerotic plaque formation. Previous studies also
demonstrated that hypercholesterolemia, hypertension, diabetes, and dysfunction of endothelium are the common facilitating factors for atherosclerosis.[1,2] However, there are
substantial differences in its incidence, prevalence and mortality across countries and ethnicities. Morbidity and mortality of cardiovascular disease have decreased significantly in
developed countries, but continue to rise in developing
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countries.[3] The changes in lifestyle and diet have lead to an
increase of life expectancy, but also of the burden of cardiovascular disease and other chronic diseases.[4] Developing efficient preventive approaches for atherosclerosis progression may be an effective strategy to minimize the risk of
cardiovascular events among general populations. Early
detection may lead to optimum therapeutic intervention.
Noninvasive measurement of the subclinical atherosclerotic
burden in asymptomatic people has the potential to improve
assessment of cardiovascular risk and might contribute to a
more effective prevention of cardiovascular events.
Recently, the discovery that pericardial fat may locally
affect coronary arterial through generation of inflammatory
cytokines.[5] Moreover, coronary artery calcification has
been strongly recommended to be added as one of the risk
factors for predicting adverse cardiovascular events.[6] In
terms of technology, non-contrast chest computed tomography (NCT) can be routinely performed to detect pericardial fat volume (PFV) and measure coronary artery calcification score (CACS).[7,8] Given the high prevalence of
atherosclerosis, studying risk factors or characteristics for
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atherosclerosis in Chinese population will have greater public health and clinical implications.
A growing body of evidence reveals that cardiac fat deposits maybe associated with multiple metabolic risk factors,
such as hypertension, hyperlipidaemia and diabetes, with an
unfavorable cardiometabolic risk profile suggesting that a
high pericardial fat accumulation might play a major role in
the pathogenesis of coronary atherosclerosis disease(CAD),
and as a new biomarker for cardiovascular risk assessment.[9]
Previous researches have reported CACS had correlation
with PFV, but no correlation with body mass index (BMI)
and blood lipid levels. Therefore, PFV may have a unique
role in coronary artery calcification even in atherosclerosis
progression. Nakanishi R, et al. demonstrated that increase
in epicardial fat volume is associated with greater CACS
progression in subjects at intermediate risk by coronary calcification score.[10] Contrary to the previous reports, Wassel,
et al.[11] studied the relationship between the PFV and the
coronary calcium score in 600 patients using chest computed tomography (CT) scans at two time points with an
interval of about four years, and found that PFV is not associated with the presence, severity and progression of coronary artery calcium. However, there is no comprehensive
evaluation of the effects of CACS, PFV and cardiovascular
events in China.

2 Objective
Our main aim is to spread the noninvasive imaging and
proper biomarker associated with the outcome of phased
progression of atherosclerosis in healthy people. Baseline
examination consists of screening for CACS and measurement of PFV by non-contrast chest computed tomography,
as well blood sampling for determination of traditional risk
factors will be collected. Moreover, follow-up at annual
year will include a repetition of baseline measurements and
cardiovascular events.

Figure 1. Flowchart of PERSUADE study.

time of their regular annual check up performed by the Jidong Staff Hospital.
The following are the exclusion criteria: (1) prior history
of cardiovascular disease (including myocardial infarction,
angina pectoris, stroke, peripheral vascular disease, aortic
aneurysm, angioplasty, heart surgery, atrial fibrillation,
heart failure, heart valvular diseases or any other heart disease); (2) active treatment for cancer, history of transplant
with active immunosuppressive or immunomodulator
treatment; (3) morbid obesity (body mass index ≥ 40 kg/m2),
chronic kidney disease (glomerular filtration rate < 60
mL/min per square meter), presence of any disease that decreases life expectancy to < 5 years, or any condition that
could affect adherence to the study procedures; (4) participants are also excluded if they were pregnant or lactating.
3.2 Data collection
All data is obtained at the annual medical exam that the
Jidong Oilfield provides to all workers and their family. The
clinical exam follows standardized protocols using validated
procedures and instruments. Data collection at the annual
medical exams is conducted by the physicians and nurses of
the Jidong Staff Hospital, who undergo training and standardization programs organized by the study investigators.
Basic demographic information of all participants is collected by trained doctors using validated questionnaire specifically designed for this study.

3 Methods
3.1 Study design and population cohort

3.3 Assessment of demographic variables and cardiovascular risk factors

The PERSUADE study is an observational, longitudinal,
prospective cohort study that will include 3000 asymptomatic participants of Jidong Oilfield community for a total
of 10 years of follow-up (Figure 1). The community is geographically located in Tangshan City in northern China and
is mainly comprised of employees of the Jidong Oilfield and
their family members. From April 2014, all residents aged
40 to 75 years were invited to participate in our study at the

Detailed information on demographic variables (e.g, age,
gender, household income, level of education, and previous
history of diseases) are collected. The average monthly income is categorized as “< ¥ 3,000”, “¥ 3,000–4,999” and “
¥ 5,000”. The level of education is categorized as “illiteracy
or compulsory education”, “high school” or “College/University”. The smoking status is classified as “never”, “former”, or “current” according to self-reported information.
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Body weight (kg) and body height (cm) are measured, and
the body mass index is calculated as body weight (kg) divided by the square of height (m2). Hypertension is defined
based on the following information alone or in combination:
(1) as presence of a history of arterial hypertension; (2) using antihypertensive medication; or (3) a systolic blood
pressure > 140 mmHg or a diastolic blood pressure > 90
mmHg. Diabetes mellitus is defined as a self-reported history, current treatment with insulin, oral hypoglycemic
agents or fasting blood glucose level > 126 mg/dL. Dyslipidemia is defined by a self-reported history, current use of
cholesterol lowering medicine, a total cholesterol level >
220 mg/dL or triglyceride > 150 mg/dL or low density lipoprotein > 160 mg/dL.
3.4 Laboratory analysis
At each examination, blood samples are collected from
the antecubital vein in the morning under fasting conditions.
They will be stored in vacuum tubes containing Ethylene
Diamine Tetraacetic Acid (EDTA). Fasting blood glucose
will be measured with the hexokinase/glucose-6-phosphate
dehydrogenase method. Cholesterol and triglyceride concentration will be measured enzymatically [inter-assay coefficient of variation: < 10% (Mind Bioengineering Co. Ltd,
Shanghai, China)]. For all participants, serum creatinine,
cholesterol, low-density lipoproteins (LDL-C), triglycerides
as well as glucose levels will be assessed.
3.5 Analysis of CACS and PFV
As part of the protocol, all participants will undergo NCT
for quantification of CACS and PFV. The NCT is acquired
using a 64-slice CT scanner (Siemens Dual Source 64-Slice
Definition, Forchheim, Germany). For scanning, a standard
non-contrast prospective scan will be performed. Acquired
images will be then transferred to a research workstation for
quantification of CACS and PFV. All CT images will be
initially reviewed by two experienced CT analysts using
semiautomatic, commercially available software (synoMultiModality Workplace, syngoMMWP VW 40A).
CACS is defined as a focus of at least four contiguous
pixels with a CT density of > 130 Hounsfield units (HU)
and quantified using the Agatston method. Total Agatston
CACS is calculated as the sum of calcified plaque scores of
all coronary arteries. Pericardial fat includes all adipose
tissue enclosed by the visceral pericardium, involving all fat
directly surrounding the coronary arteries. Image data will
be processed as following. First, the upper slice limit
marked by bifurcation of the pulmonary trunk, and lower
slice limit identified as the last slice containing any portion
of the heart, are manually chosen by an expert reader

blinded to patient status and clinical NCT interpretation.
Next, the reader defines five to seven control points on the
pericardium in each transverse view. The PFV is then
automatically calculated (reported in cm3). Contiguous
3-dimensional voxels between the HU limits of –195 to –45
are defined as fat voxels.
3.6 Follow up and outcome assessment
Participants will be followed up by face-to-face interviews every year in a routine medical examination. Data on
clinical outcomes will be collected through a standard operational procedure follow up system. The follow up system
involves linkage of the study database to files from general
practitioners, medical specialists and discharge reports in
case of hospitalization. With respect to the vital status of
participants, the information is also obtained regularly from
the municipal health authorities in Tangshan city. After notification, cause and circumstances of death will be diagnosed by general practitioners using questionnaire.
The disease diagnosis will be confirmed only after review of the medical records by an End Points Committee of
physicians that includes a cardiologist, neurologist, cancer
experts, etc. The End Points Committee of physicians including membership, role and responsibilities will be approved before the start of the study by the executive committee. Primary endpoints are major adverse cardiovascular
events (MACE) including cardiac death, myocardial infarction, stroke and revascularization. In brief, questionnaires on
the current state of health including questions about current
medications, hospital admissions, and outpatient diagnosis
of cardiovascular disease are annually sent to the participants. In parallel, all death certificates are regularly screened.
Incident cardiovascular morbidity and fatal events will be
validated by reviewing hospital records and records of the
attending physicians, and classified by an external endpoint
committee, blinded to the risk factor status and the CACS.
3.7 Statistical analyses
The data management system including the statistical
analysis is performed using the SAS software (version 9.4;
SAS Institute, Cary, North Carolina, USA). Firstly, the distributions (mean ± SD) of the parameters are calculated.
Normal distribution of the parameters is assessed using the
Kolmogorov-Smirnoff test. Secondly, the parameters are
compared between the groups, using either the student’s t
test for paired or non-paired samples of normally distributed
parameters or the Wilcoxon-Mann-Whitney test or the
Wilcoxon test for non-parametric variables. The Chisquared test is applied for the comparison of categorical
variables. Thirdly, multivariate associations between the
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various parameters are performed using multivariable regression analyses or binary regression analyses. Fourthly, a
longitudinal assessment of associations and a survival
analysis for the combination of major vascular events and
for each vascular event will be performed using the Kaplan-Meier curves in relation to PFV. Cox multivariate regression models will be used to compare the probability of
having a vascular event in the follow-up cohorts, adjusting
for the possible confounders. The hazards ratios (HR) will
be presented with their corresponding 95% confidence intervals (CI). The level for statistical significance will be set
at α = 0.05 (two-tailed).
3.8 Ethics statement
The study protocol is complied with the World Medical
Association Declaration of Helsinki and China’s regulations
and guidelines on good clinical practice. Ethical clearance
for the trial has obtained from the Ethical Committee of the
Jidong Staff Hospital. Informed consents will be obtained
from all participants before recruiting into the study.

4 Discussion
The PERSUADE study will prospectively evaluate the
relation between non-invasive CT imaging based risk factors and phased progression of atherosclerosis in asymptomatic population in China. In a planned long-term follow up,
data from clinical parameters, laboratory tests, CACS, PFV
and the occurrence of cardiovascular events will be collected longitudinally to build up a predicting model for the
risk of atherosclerosis progression.
Atherosclerosis is a long-term condition that progresses
over many decades. It usually produces no symptoms until
that arterial narrowing significantly reduces blood supply to
an organ. So early intervention and preventive strategies
have become major targets for predictive, preventive and
personalized medical studies. Previous hospital-based studies have indicated relationship between traditional cardiovascular risk factors and atherosclerosis progression.[12–16]
For example, participants from the cohort of the Korean
Atherosclerosis Study 2 (n = 402, mean age of 54 years,
57.0% men) underwent 64-slice multi-detector row computed tomography (MDCT) to assess pericardial fat amount,
CACS, severity of coronary artery stenosis, and plaque
characteristics. Patients with atherosclerotic lesion had significantly larger volume of pericardial fat than patients
without atherosclerosis (308 ± 96 cm3 vs. 251 ± 93 cm3; P
< 0.01).[7] Our study is a population based survey, and the
participants underwent NCT for CACS and PFV measurement every year to evaluate the atherosclerosis risk factors.

In this study, we had focus on the CACS and PFV by
NCT. NCT screening requires no preparation and avoids the
use of intravenous contrast. This technique can be operated
in any participants able to lay flat and perform a single
breath hold. The participant is exposed to a low dose of radiation less than 1 mSv, akin to mammography and less
than annual exposure from natural sources(3–4 mSv). To
date, CACS has been applied to more than 100,000 participants, including multiple large prospective studies with up
to 10-year follow up.[17,18] Across these studies, CACS has
demonstrated a consistent ability to assess cardiovascular
risk in asymptomatic patients beyond that provided by alternative noninvasive tests and risk calculators. In a subset
of participants in the cardiovascular health study, CACS and
intima-media thickness (IMT) seemed to predict CVD
events in a similar manner, but IMT outperformed CACS
for stroke prediction.[19]
It has been postulated that paracrine effects of pericardial
fat may be a potent determinant of coronary plaque development and progression. Pericardial fat, owing to the anatomical proximity with coronary arteries and heart, has been
found to contain higher levels of inflammatory markers and
adipokines that can locally accelerate the atherosclerotic
process by endothelial dysfunction, local proliferation of
smooth muscle cells and increased plaque instability
through apoptosis and neovascularization.[20, 21] PFV increment has been observed to have a strong association with
various inflammatory marker changes and early coronary
endothelial dysfunction that may precede coronary calcification and the development of mature atherosclerotic changes.
The present study has several strengths, including its
large sample size, the stability and low mobility may facilitate longtime follow up examinations. Moreover, our NCT
is noninvasive examination and radiation dose is very low.
Nevertheless, several limitations of this study should be
considered. Firstly, this is a single-centre investigation, and
the participants are in the northern of China, so it couldn’t
completely stand for whole Chinese population. Secondly,
our measuring method for quantifying PFV is semi-automatic and we cannot accurately measure the epicardial fat
volume by non-contrast methods. Thirdly, because of the
non contrast, we can not obtain the condition of coronary
artery stenosis.
In brief, the PERSUADE study is expected to analyze the
clinical characteristics of asymptomatic people and to set up
risk stratification model by collecting the cardiac CT imaging and risk factors. Combining with follow up of cardiovascular events, the present study may help to achieve early
detection, early prevention of the cardiovascular disease and
establish a more personalized treatment of clinical practice.
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5 The study status
This program began in April 2014 and patients’ follow
up visit is ongoing now. The baseline clinical information
was collection and exam data will be transfer and arrange
into our database every year then.
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